Bringing Groundbreaking Treatments to Patients with Psychiatric and Neurodegenerative Diseases

Unleashing unique properties and biological effects of Noble gases for treatment of PTSD, Autism, Dementia

Combining revolutionary portable inhalation device with a safe therapeutic

Accelerated pathway of clinical development

Scientific Advisory Board

Daqin Ma, MD, PhD. 

Dr. Ma is a Macintosh Professor of Anesthesia and the Head of Anesthesia Research at the Imperial College of London. He is a well-recognized opinion leader in the field of xenon research, who has published extensively and has discovered a numbers of previously unknown therapeutic properties of this noble gas. Dr. Ma received his MD degree in China and his PhD at the Imperial College of London, and is the recipient of 3 postdoctoral fellowships, including University College London, Duke University and ICL, where he and his co-workers  were first to discover the neuroprotective properties of xenon gas.  He has more than 180 publications in high impact peer reviewed journals covering research fields of Anesthesiology, Pharmacology, Neuroscience, Neurology and Nephrology, and is a holder of two international patents. His main research interests are organoprotection, postoperative cognitive dysfunction, cancer and pain. Dr. Ma’s research has been supported by the grants from MRC, Alzheimer’s Society-Bupa Foundation, BJA/RCoA, AAGBI, Westminster Medical School Research Trust, Action Medical Research and SPARKS, UK and European Society of Anesthesiology, Brussels. He is a regular invited reviewer for over 50 peer reviewed journals. He is a co-inventor on the Company’s patent on the use of noble gases in treatment of Alzheimer’s disease.

Santosh Kesari, MD, Ph.D.

Dr. Kesari is the Chairman of the Department of Translational Neuro-Oncology and Neurotherapeutics at the John Wayne Cancer Institute and Director of Neuro-Oncology at Providence Saint John’s Health Center. An internationally recognized scientist and clinician, he is ranked in the top 1% of neuro-oncologists and neurologists in the United States by Castle Connolly Medical Ltd.

Dr. Kesari graduated from University of Pennsylvania’s School of Arts and Sciences in 1992 and received a PhD in molecular biology and an MD from the University of Pennsylvania’s School of Medicine. He completed his residency in neurology at the Massachusetts General Hospital, Brigham and Women’s Hospital and Harvard Medical School, and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston. He was an assistant professor of neurology at Harvard Medical School, Dana-Farber Cancer Institute and Brigham and Women’s Hospital and later professor of neurosciences at the University of California, San Diego. He is on the advisory boards of the American Brain Tumor Association, the San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices against Brain Cancer and the Philippine Brain Tumor Alliance. Dr. Kesari is a co-inventor on the Company’s patent on the use of noble gases in post-radiation neuroprotection.

Steven E. Arnold, MD. 

Dr. Arnold is a Professor and a Translational Neurology Head of the Interdisciplinary Brain Center at Massachusetts General Hospital at Harvard University. Prior to that Dr. Arnold was a Professor of Psychiatry and Neurology at the University of Pennsylvania. After receiving his B.A. and M.D. degrees from Boston University, Dr. Arnold completed residency training in Psychiatry at the New York State Psychiatric Institute / Columbia Presbyterian Medical Center in New York and residency training in Neurology at the University of Iowa Hospitals and Clinics in Iowa City. He also completed fellowship training in Behavioral Neurology /Cognitive Neuroscience and was a post-doctoral associate in Neuroanatomy in Iowa.  Dr. Arnold is board certified in both neurology and psychiatry. While at Penn, Dr. Arnold was Director of the Penn Memory Center of the University of Pennsylvania Health System, Associate Director and Clinical Core Leader of the Alzheimer’s Disease Core Center, Director of the Geriatric Psychiatry Section in the Department of Psychiatry, Director of the Cellular and Molecular Neuropathology Program in the Center for Neurobiology and Behavior, and Associate Director of the University of Pennsylvania’s Institute on Aging. Dr. Arnold has authored more than 250 scientific articles and his research has garnered numerous awards.